HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45658,
"recordsTotal": 45658,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=41400",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=registry_id&start=40800",
"results": [
{
"registry_id": "NCT06944522",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06944522",
"title": "exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueRock Therapeutics",
"sponsor_slug": "bluerock-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639464",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06639464",
"title": "Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947928",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06947928",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Of IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Checkpoint-Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TuHURA Biosciences, Inc.",
"sponsor_slug": "tuhura-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788964",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06788964",
"title": "A Phase 2 Study of Loncastuximab Tesirine and Rituximab as Bridging Therapy Prior to Standard-of-care CD19 CAR T-cell Therapy in Patients With Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06803602",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06803602",
"title": "Evaluating the Efficacy of High-Intensity Focused Electromagnetic Technology in Improving the Time of Recovery of Urinary Control of Continence and Quality of Life for Post-Surgical Patients",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07065240",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07065240",
"title": "A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults With Major Depressive Disorder (MDD), With or Without Anxious Distress",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seaport Therapeutics",
"sponsor_slug": "seaport-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963710",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06963710",
"title": "A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects With Chronic Hepatitis B Virus Infection (B-SUPREME)",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aligos Therapeutics",
"sponsor_slug": "aligos-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06888921",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06888921",
"title": "An Adaptive Clinical Platform Trial to Evaluate the Safety and Efficacy of COM701 as Monotherapy or Combination Therapy as Maintenance Therapy in Participants With Relapsed Platinum Sensitive Ovarian Cancer (PSOC)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Compugen Ltd",
"sponsor_slug": "compugen-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06067802",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06067802",
"title": "A Phase II, Escalating Dose, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jerry Vockley, MD, PhD",
"sponsor_slug": "jerry-vockley-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956209",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06956209",
"title": "A First-in-Human, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of an Implantable Device for Direct Bladder Wall Stimulation in Participants With Lower Urinary Tract Symptoms of Underactive Bladder",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iota Biosciences, Inc",
"sponsor_slug": "iota-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07036523",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07036523",
"title": "A Double-blind, Randomised, Placebo-controlled, Parallel Group, Phase IIa Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 765423 Administered Intravenously With or Without Standard of Care in Patients With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820723",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06820723",
"title": "A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07073950",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07073950",
"title": "A Randomised, Double-blind, Multi-centre, Placebo-controlled, Crossover Study to Assess the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler on Cardiac and Lung Function in Participants With Chronic Obstructive Pulmonary Disease and Hyperinflation",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07018700",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07018700",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Episodic Migraine",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merz Therapeutics GmbH",
"sponsor_slug": "merz-therapeutics-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05754216",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05754216",
"title": "Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04777500",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04777500",
"title": "Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia",
"has_exemption": false,
"start_date": "2026-01-03",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06013449",
"title": "Investigation of the Effect of Simultaneous Pulsed Electromagnetic Field (PEMF) and Intravesical Heparin - Bupivacaine Cocktail Instillation for the Symptomatic Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06443177",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06443177",
"title": "The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2027-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02046330",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02046330",
"title": "Deep Brain Stimulation (DBS) Therapy for Treatment Resistant",
"has_exemption": false,
"start_date": "2013-12-16",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02231775",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02231775",
"title": "Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)",
"has_exemption": false,
"start_date": "2014-10-22",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02484248",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02484248",
"title": "Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia",
"has_exemption": false,
"start_date": "2015-08-31",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03574571",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03574571",
"title": "Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2018-06-19",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04693377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04693377",
"title": "Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases",
"has_exemption": false,
"start_date": "2021-03-16",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04682158",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04682158",
"title": "Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma A Phase II Study",
"has_exemption": false,
"start_date": "2021-04-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05108818",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05108818",
"title": "Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04862221",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04862221",
"title": "A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients",
"has_exemption": false,
"start_date": "2022-02-09",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05319509",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05319509",
"title": "Pilot Study of Virtual Reality Therapy for Students With Anxiety",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05271240",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05271240",
"title": "A Phase III Randomized Trial of Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab (Avastin) With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed Glioblastoma (GBM)",
"has_exemption": false,
"start_date": "2022-04-27",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046353",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05046353",
"title": "D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase",
"has_exemption": false,
"start_date": "2022-12-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919264",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05919264",
"title": "A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Parabilis Medicines, Inc.",
"sponsor_slug": "parabilis-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05547048",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05547048",
"title": "Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027788",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06027788",
"title": "Embolic Protection in Patients Undergoing High-Risk Valve Surgery",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320405",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06320405",
"title": "A Phase Ib/II Study of Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06383572",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06383572",
"title": "Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies",
"has_exemption": false,
"start_date": "2024-06-26",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06258447",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06258447",
"title": "Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure II Trial",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "BioCardia, Inc.",
"sponsor_slug": "biocardia-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06655376",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06655376",
"title": "Delayed ARIES: Aspirin and Hemocompatibility Events in Advanced Heart Failure Patients Chronically Supported with a Left Ventricular Assist Device",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06716580",
"title": "EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868628",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06868628",
"title": "A Phase 2a Study to Evaluate Microglial Activation, Safety, and Clinical Effects of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06972628",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06972628",
"title": "177Lu-PSMA-617 (Pluvicto) for the Treatment of Patients With Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Super Scan Bone Scan",
"has_exemption": false,
"start_date": "2025-05-23",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ebrahim S Delpassand",
"sponsor_slug": "ebrahim-s-delpassand",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02199015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02199015",
"title": "Lateral Cord Electrical Stimulation Can Improve Spasticity in Chronic Spastic Cerebral Palsy",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Juan Carlos M. Andreani MD",
"sponsor_slug": "juan-carlos-m-andreani-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969287",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06969287",
"title": "Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05975580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05975580",
"title": "Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery",
"has_exemption": false,
"start_date": "2023-08-29",
"completion_date": "2027-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06334523",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06334523",
"title": "Open Randomised Study of Conventional Ventilation Optimised by Dead Space Washout in Extremely Premature Infants",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2027-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Centre Hospitalier Intercommunal Creteil",
"sponsor_slug": "centre-hospitalier-intercommunal-creteil",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04636814",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04636814",
"title": "A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.",
"has_exemption": false,
"start_date": "2021-07-12",
"completion_date": "2027-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05374278",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05374278",
"title": "First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in the Brains of Healthy Controls and Patients With Dementia.",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2027-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "David Wilson",
"sponsor_slug": "david-wilson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730816",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05730816",
"title": "MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI",
"has_exemption": false,
"start_date": "2023-04-04",
"completion_date": "2027-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04015141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04015141",
"title": "An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy",
"has_exemption": false,
"start_date": "2019-05-31",
"completion_date": "2027-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04421963",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04421963",
"title": "Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib and Are Judged by the Investigator to Clinically Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2020-08-04",
"completion_date": "2027-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05331183",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05331183",
"title": "A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes",
"has_exemption": false,
"start_date": "2022-11-23",
"completion_date": "2027-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04481204",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04481204",
"title": "PIONEER-Panc: Phase II Investigations of New and Emerging Therapies for Pancreatic Cancer",
"has_exemption": false,
"start_date": "2023-04-18",
"completion_date": "2027-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07000136",
"title": "A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2027-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03930953",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03930953",
"title": "A Phase 1/2, Multi-center, Open-label Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of an Orally Available Small Molecule, CC-99282, Alone and in Combination With Anti-Lymphoma Agents in Subjects With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL).",
"has_exemption": false,
"start_date": "2019-05-20",
"completion_date": "2027-04-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03651128",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03651128",
"title": "A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)",
"has_exemption": false,
"start_date": "2019-04-16",
"completion_date": "2027-04-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05286788",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05286788",
"title": "Phase 2 Study of the MEK Inhibitor MEKTOVI® (Binimetinib) for the Treatment of Pediatric Adamantinomatous Craniopharyngioma",
"has_exemption": false,
"start_date": "2023-04-10",
"completion_date": "2027-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06734195",
"title": "Comparing the Synergistic Effect of Caudal Dexmedetomidine and Propofol Versus Caudal Dexmedetomidine Only or Propofol Only in Prevention of Sevoflurane Related Emergence Agitation in Pediatric Patients Undergoing Congenital Inguinal Hernia Repair: Randomized Double-blind Controlled Study",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2027-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669664",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05669664",
"title": "A Phase 2 Study of Darolutamide in Combination With Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer",
"has_exemption": false,
"start_date": "2023-07-20",
"completion_date": "2027-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666790",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06666790",
"title": "DermaSensor Postmarket Surveillance Study",
"has_exemption": false,
"start_date": "2024-10-08",
"completion_date": "2027-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "DermaSensor, Inc.",
"sponsor_slug": "dermasensor-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687980",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06687980",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2027-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687967",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06687967",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults",
"has_exemption": false,
"start_date": "2024-11-28",
"completion_date": "2027-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05549258",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05549258",
"title": "An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2027-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765642",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06765642",
"title": "Evaluation of 3 Patterned rTMS Stimulation Dosage on Corticospinal Excitability and Motor Learning in Stroke Patients",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2027-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06954805",
"title": "Defining the Role of ctDNA Monitoring in a Risk Stratified Clinical Trial for Posttransplant Lymphoproliferative Disorder (PTLD)",
"has_exemption": false,
"start_date": "2025-04-14",
"completion_date": "2027-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer Amengual",
"sponsor_slug": "jennifer-amengual",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815497",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06815497",
"title": "Phase II Non-Randomized, Unblinded, Single-Center Trial of Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer Versus Historical Best Supportive Care",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2027-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyler J Curiel",
"sponsor_slug": "tyler-j-curiel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04074746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04074746",
"title": "Bispecific NK Engager AFM13 Combined With NK Cells for Patients With Recurrent of Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2020-07-18",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05472792",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05472792",
"title": "Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN)",
"has_exemption": false,
"start_date": "2022-05-17",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456346",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06456346",
"title": "A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK-3543) Versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05602779",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05602779",
"title": "Leveraging Noninvasive Transcutaneous Vagus Nerve Stimulation and Smartphone Technology to Reduce Suicidal Behaviors and Suicide Among Highly Vulnerable Adolescents",
"has_exemption": false,
"start_date": "2024-11-15",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Notre Dame",
"sponsor_slug": "university-of-notre-dame",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05553353",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05553353",
"title": "Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06691893",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06691893",
"title": "A Randomized Controlled Trial to Evaluate the Efficacy of Immobilized Lipase (RELiZORB) During Enteral Nutrition in Patients With Exocrine Pancreatic Insufficiency Secondary to Acute Pancreatitis",
"has_exemption": false,
"start_date": "2025-03-28",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06633900",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06633900",
"title": "Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934200",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06934200",
"title": "Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06706362",
"title": "Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06271707",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06271707",
"title": "Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06655883",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06655883",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Suvorexant for the Treatment of Insomnia in Participants With Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364904",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06364904",
"title": "A Multicenter, III Stage, Randomized Controlled Trail on the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib in Untreated Unresectable and Metastatic Urothelial Carcinoma.",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
"sponsor_slug": "sun-yat-sen-memorial-hospital-of-sun-yat-sen-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833154",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03833154",
"title": "A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) Osimertinib Following SBRT, a Single Arm Cohort for Patients With Unresected Stage I/II, Lymph Node Negative NSCLC Harboring a Sensitizing EGFR Mutation",
"has_exemption": false,
"start_date": "2019-03-06",
"completion_date": "2027-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05101070",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05101070",
"title": "A Phase 1b/2, Multicenter, Open-label Study of S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2027-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Shionogi",
"sponsor_slug": "shionogi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06607627",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06607627",
"title": "An Open-Label, Single-arm Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, and Efficacy of Gefurulimab in Pediatric Patients (6 to < 18 Years of Age) With Generalized Myasthenia Gravis (gMG) Who Express Acetylcholine Receptor Antibodies (AChR+)",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2027-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03839771",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03839771",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy.",
"has_exemption": false,
"start_date": "2019-03-01",
"completion_date": "2027-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06090903",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06090903",
"title": "Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2027-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06427395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06427395",
"title": "A Multicenter, Open-Label, Extension Clinical Trial to Evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2027-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05774951",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05774951",
"title": "CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Without Disease Recurrence",
"has_exemption": false,
"start_date": "2023-03-31",
"completion_date": "2027-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04031677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04031677",
"title": "A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (RPS)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2027-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "European Organisation for Research and Treatment of Cancer - EORTC",
"sponsor_slug": "european-organisation-for-research-and-treatment-of-cancer-eortc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647407",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06647407",
"title": "A Parallel-group Prevention, Phase II, Partially Blinded, Multi-stage Study to Investigate the Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine Formulations Compared With Licensed Meningococcal Vaccines When Administered Alone in Healthy Children (2 to 9 Years of Age) or Concomitantly With Routine Pediatric Vaccines in Toddlers (12 to 15 Months of Age) and Infants (2 Months of Age).",
"has_exemption": false,
"start_date": "2024-11-05",
"completion_date": "2027-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769698",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06769698",
"title": "Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2027-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06713668",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06713668",
"title": "Augmented Pacing for Shock in the Cardiac Intensive Care Unit - A Pilot Patient-level Crossover Trial",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2027-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06868212",
"title": "A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihistamines",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2027-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05639114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05639114",
"title": "A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)",
"has_exemption": false,
"start_date": "2023-03-02",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624749",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05624749",
"title": "A Randomized, Double-blind, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06305767",
"title": "A Phase 1/2 Study of V940 Plus Pembrolizumab With or Without Enfortumab Vedotin in Muscle-Invasive Urothelial Carcinoma (MIUC) (INTerpath-005)",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06242834",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06242834",
"title": "Phase II, Single Arm, Open Label, Study of the Combination of Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-Cell Therapy in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2027-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04929392",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04929392",
"title": "A Phase 2 Trial of Neoadjuvant Chemoradiation With Pembrolizumab Followed by Pembrolizumab With Lenvatinib in Esophageal/Gastroesophageal Junction Squamous Cell and Adenocarcinomas",
"has_exemption": false,
"start_date": "2022-01-25",
"completion_date": "2027-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785624",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05785624",
"title": "A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2023-05-26",
"completion_date": "2027-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06452277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06452277",
"title": "A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2027-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04590326",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04590326",
"title": "Phase 1/2 Study of REGN5668 (MUC16xCD28, a Costimulatory Bispecific) Administered in Combination With Cemiplimab or REGN4018 (MUC16xCD3)",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04959175",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04959175",
"title": "Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies",
"has_exemption": false,
"start_date": "2021-09-23",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05379595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05379595",
"title": "A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2022-07-29",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023627",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07023627",
"title": "A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173937",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03173937",
"title": "Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, to Expedite Engraftment and Improve Transplant Outcome",
"has_exemption": false,
"start_date": "2017-06-13",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05529069",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05529069",
"title": "Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194448",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06194448",
"title": "A Phase II, Open-label, Single-arm Study of Osimertinib as Induction Therapy Prior to CRT and Maintenance Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Stage III, Unresectable Non-small Cell Lung Cancer (NEOLA)",
"has_exemption": false,
"start_date": "2024-04-21",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238622",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06238622",
"title": "An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)",
"has_exemption": false,
"start_date": "2024-09-24",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952556",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06952556",
"title": "A Randomized, Single-blind, Single-center Study Measuring the Effects of Adductor Canal Block Combined With IPACK Infiltration Compared to Adductor Canal Block Alone on Post-operative Pain and Opioid Consumption in Patients Undergoing HTO/DFO/TTO",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918132",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06918132",
"title": "Phase II Single Arm Study of Neoadjuvant Dual Checkpoint Blockade With Programmed Death-ligand 1 (PD1) and Lymphocyte Activation Gene 3 (LAG-3) Inhibition in Resectable Non-Small Cell Lung Cancer (N-PLANC)",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2027-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01512589",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01512589",
"title": "Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer",
"has_exemption": false,
"start_date": "2012-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01787487",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01787487",
"title": "Evaluation of Ruxolitinib and Azacytidine Combination as a Therapy for Patients With Myelofibrosis and Myelodysplastic Syndrome/ Myeloproliferative Neoplasm",
"has_exemption": false,
"start_date": "2013-03-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02227251",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02227251",
"title": "A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
"has_exemption": false,
"start_date": "2014-11-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02181257",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02181257",
"title": "Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts",
"has_exemption": false,
"start_date": "2015-01-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02420860",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02420860",
"title": "Phase II Study of the Combination of Elotuzumab With Lenalidomide as Maintenance Therapy Post Autologous Stem Cell Transplant in Patients With Multiple Myeloma",
"has_exemption": false,
"start_date": "2015-04-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02343042",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02343042",
"title": "A Phase 1b/2 Study of Selinexor (KPT-330) in Combination with Backbone Treatments for Relapsed/Refractory Multiple Myeloma and Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2015-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960555",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02960555",
"title": "Phase II Trial of Isatuximab (SAR650984) With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)",
"has_exemption": false,
"start_date": "2017-02-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03090633",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03090633",
"title": "Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida",
"has_exemption": false,
"start_date": "2017-05-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03360721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03360721",
"title": "A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature",
"has_exemption": false,
"start_date": "2018-03-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03449108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03449108",
"title": "Clinical Study to Assess Efficacy and Safety of LN-145/LN-145-S1 (Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types",
"has_exemption": false,
"start_date": "2018-04-27",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03298334",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03298334",
"title": "Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2018-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03540758",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03540758",
"title": "Regulation of Endogenous Glucose Production by Central KATP Channels",
"has_exemption": false,
"start_date": "2018-08-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Meredith Hawkins",
"sponsor_slug": "meredith-hawkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03586609",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03586609",
"title": "Phase II Study of Venetoclax Added to Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed by Consolidation With Cladribine Plus LDAC Alternating With 5-Azacitidine With Venetoclax in Patients With Untreated AML",
"has_exemption": false,
"start_date": "2018-10-25",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04176198",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04176198",
"title": "A Phase 1/2, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral Nuvisertib (TP-3654) in Patients With Intermediate or High-Risk Primary or Secondary Myelofibrosis",
"has_exemption": false,
"start_date": "2019-12-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03907046",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03907046",
"title": "Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery",
"has_exemption": false,
"start_date": "2020-01-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05986292",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05986292",
"title": "A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04280718",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04280718",
"title": "Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2020-09-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04583644",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04583644",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2020-10-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hanmin Lee",
"sponsor_slug": "hanmin-lee",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04221815",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04221815",
"title": "IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)",
"has_exemption": false,
"start_date": "2020-10-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04402788",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04402788",
"title": "RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial",
"has_exemption": false,
"start_date": "2021-01-07",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03892980",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03892980",
"title": "A Prospective, Multicenter Investigation of the da Vinci® Surgical Systems in Nipple Sparing Mastectomy (NSM) Procedures",
"has_exemption": false,
"start_date": "2021-03-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intuitive Surgical",
"sponsor_slug": "intuitive-surgical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05056844",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05056844",
"title": "Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04956640",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04956640",
"title": "A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-07-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905069",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04905069",
"title": "Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05011188",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05011188",
"title": "A Phase 1b/2 Study of FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2022-01-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04988555",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04988555",
"title": "A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of DSP-5336 in Adult Patients With Acute Leukemia and Other Selected Hematologic Malignancies, With and Without Mixed Lineage Leukemia (MLL) Rearrangement or Nucleophosmin 1 (NPM1) Mutation",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05353569",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05353569",
"title": "Otitis Media Diagnosis and Treatment: Coherent Optical Detection of Middle Ear Disease",
"has_exemption": false,
"start_date": "2022-05-24",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06850922",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06850922",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Patients With Diabetic Macular Edema",
"has_exemption": false,
"start_date": "2022-06-22",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05285527",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05285527",
"title": "MiSight 1 Day Safety Post-Approval Study",
"has_exemption": false,
"start_date": "2022-08-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Coopervision, Inc.",
"sponsor_slug": "coopervision-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05596318",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05596318",
"title": "Efficacy of Digital Cognitive Behavior Therapy for Insomnia for the Prevention of Perinatal Depression",
"has_exemption": false,
"start_date": "2022-11-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05279742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05279742",
"title": "Enhancing the Natriuretic Peptide System in HFpEF: a Randomized Double-Blind Placebo-Controlled Triple Crossover Study",
"has_exemption": false,
"start_date": "2022-11-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Horng Chen",
"sponsor_slug": "horng-chen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05185505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05185505",
"title": "Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667142",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05667142",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures",
"has_exemption": false,
"start_date": "2023-02-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xenon Pharmaceuticals Inc.",
"sponsor_slug": "xenon-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118268",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06118268",
"title": "iTBS to Enhance Social Cognition in People With Psychosis",
"has_exemption": false,
"start_date": "2023-04-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613608",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05613608",
"title": "Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies",
"has_exemption": false,
"start_date": "2023-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646485",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05646485",
"title": "Optimal Screening Strategy for Bladder Cancer in at Risk Patients",
"has_exemption": false,
"start_date": "2023-05-05",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05683691",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05683691",
"title": "Prospective, Multicenter, Single-Arm Study of VanquishTM Water Vapor Ablation for PrOstate CanceR",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Francis Medical Inc.",
"sponsor_slug": "francis-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05703256",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05703256",
"title": "Confirmatory Efficacy Randomized Clinical Trial of Amygdala Neurofeedback for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2023-06-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kymberly Young",
"sponsor_slug": "kymberly-young",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05531656",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05531656",
"title": "Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Over 18 Months.",
"has_exemption": false,
"start_date": "2023-06-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cognition Therapeutics",
"sponsor_slug": "cognition-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933148",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05933148",
"title": "Network-based Real-time Neurofeedback Using Ultra-high Field MRI to Reduce Rumination Levels in Depression",
"has_exemption": false,
"start_date": "2023-07-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04808505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04808505",
"title": "An Open-label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Cipaglucosidase Alfa/Miglustat in Both ERT-experienced and ERT-naïve Pediatric Subjects With Infantile-onset Pompe Disease Aged 0 to < 18 Years",
"has_exemption": false,
"start_date": "2023-07-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Amicus Therapeutics",
"sponsor_slug": "amicus-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05559879",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05559879",
"title": "A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma",
"has_exemption": false,
"start_date": "2023-08-20",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696626",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05696626",
"title": "An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sermonix Pharmaceuticals Inc.",
"sponsor_slug": "sermonix-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05291676",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05291676",
"title": "Systems Investigation of Vaccine Responses in Aging and Frailty",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111586",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06111586",
"title": "A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2b Study With a 52-week Blinded Extension Assessing Safety and Efficacy of Frexalimab, a CD40L-antagonist Monoclonal Antibody, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Newly Diagnosed Type 1 Diabetes on Insulin Therapy",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494891",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06494891",
"title": "Translational Underpinnings of Motivation for Alcohol in Humans",
"has_exemption": false,
"start_date": "2024-01-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06244082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06244082",
"title": "A Phase 2 Open-label Study to Evaluate the Pharmacodynamics and Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants With Mutations Amenable to Exon 44 Skipping",
"has_exemption": false,
"start_date": "2024-01-22",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06189638",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06189638",
"title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients With Mild Infections of Diabetic Foot Ulcers",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.",
"sponsor_slug": "jiangsu-protelight-pharmaceutical-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06095505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06095505",
"title": "A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Puma Biotechnology, Inc.",
"sponsor_slug": "puma-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458062",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06458062",
"title": "Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06280352",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06280352",
"title": "Prospective Randomized Controlled Trial of Functionally Aligned Robotically Assisted Total Knee Arthroplasty vs Patient Specific Custom Made Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Austrian Workers Compensation Board Styria",
"sponsor_slug": "austrian-workers-compensation-board-styria",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05932615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05932615",
"title": "Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement",
"has_exemption": false,
"start_date": "2024-03-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06257056",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06257056",
"title": "Closed Loop Neuromodulation for Treatment-refractory Schizophrenia: A Pilot Study",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bradley Lega",
"sponsor_slug": "bradley-lega",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152653",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06152653",
"title": "The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC",
"has_exemption": false,
"start_date": "2024-04-09",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05830942",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05830942",
"title": "Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05219175",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05219175",
"title": "MDMA-Assisted Therapy 6 to 12 Months After Childbirth for People With Co-occurring Opioid Use and Post Traumatic Stress Disorders",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377566",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06377566",
"title": "BV-AVD in Patients With Newly-Diagnosed, Early Stage, Bulky Hodgkin Lymphoma Using a PET-adapted and MTV-guided Approach",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05988918",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05988918",
"title": "A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06394804",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06394804",
"title": "Combination Targeted and Hormonal treAtMEnt of Low-gradE Serous Ovarian Cancer in the upfroNt Setting",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06048484",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06048484",
"title": "A Phase 2, Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination With Immune Checkpoint Blockade and Radiation Therapy in Patients With Advanced PANCreatic Ductal Adenocarcinoma Who Are Candidates for Surgical Resection",
"has_exemption": false,
"start_date": "2024-05-10",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gulam Manji",
"sponsor_slug": "gulam-manji",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06372964",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06372964",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lumateperone for the Treatment of Major Depressive Episodes (MDEs) Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) in Pediatric Patients Aged 10 to 17 Years",
"has_exemption": false,
"start_date": "2024-05-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05419492",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05419492",
"title": "ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Infants and Children With SCN1A-Positive Dravet Syndrome",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Encoded Therapeutics",
"sponsor_slug": "encoded-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06203210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06203210",
"title": "A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06278779",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06278779",
"title": "Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The George Institute",
"sponsor_slug": "the-george-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384664",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384664",
"title": "Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399757",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06399757",
"title": "A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apollo Therapeutics Ltd",
"sponsor_slug": "apollo-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06162572",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06162572",
"title": "A Phase 1b/2, Multicenter, Open-label Platform Study of Select Immunotherapy Combinations in Adult Participants With Previously Untreated Advanced Non-small Cell Lung Cancer (NSCLC) With High PD-L1 Expression",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06423430",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06423430",
"title": "Treatment ResistAnt Depression Subcallosal CingulatE Network DBS",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384976",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384976",
"title": "KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2024-09-20",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06456567",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "RemeGen Co., Ltd.",
"sponsor_slug": "remegen-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06598462",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06598462",
"title": "A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study with an Open Label Extension to Investigate the Efficacy and Safety of NSI-8226 in Adults with Eosinophilic Esophagitis (ALAMERE)",
"has_exemption": false,
"start_date": "2024-10-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Uniquity One (UNI)",
"sponsor_slug": "uniquity-one-uni",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06656364",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06656364",
"title": "Esprit BTK Post-Approval Study (Esprit BTK PAS)",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384651",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06384651",
"title": "Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494904",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06494904",
"title": "ED-Initiated Standard Versus High Dose Buprenorphine Induction",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06489028",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06489028",
"title": "A Pivotal, Randomized, Placebo-controlled, Double-blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "RHEACELL GmbH & Co. KG",
"sponsor_slug": "rheacell-gmbh-co-kg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06696313",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06696313",
"title": "Radiographic Migration Analysis of the Insignia Hip Stem",
"has_exemption": false,
"start_date": "2024-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Radiostereometric Analysis Network",
"sponsor_slug": "canadian-radiostereometric-analysis-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06596291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06596291",
"title": "First-In-Human Phase 1b/2a Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adult Participants With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "EG 427",
"sponsor_slug": "eg-427",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032285",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07032285",
"title": "Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas",
"sponsor_slug": "asociacion-europea-y-latinoamericana-selnet-para-la-investigacion-en-sarcomas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558188",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06558188",
"title": "Combined Anabolic Therapy Study",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289491",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06289491",
"title": "Randomized Trial of Hydrus Microstent Versus Goniotomy",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts Eye and Ear Infirmary",
"sponsor_slug": "massachusetts-eye-and-ear-infirmary",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06980805",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453785",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06453785",
"title": "Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Imperial College London",
"sponsor_slug": "imperial-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895473",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06895473",
"title": "A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06925724",
"title": "A Phase 2 Study of Ivonescimab (Bispecific Antibody Against PD1 and VEGF) For the Treatment of Endometrial (EC) and Cervical (CC) Cancers",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957327",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06957327",
"title": "A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma",
"has_exemption": false,
"start_date": "2025-04-25",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470035",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06470035",
"title": "A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Major Depressive Disorder (MDD) - Modius Mood Study",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurovalens Ltd.",
"sponsor_slug": "neurovalens-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06748144",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06748144",
"title": "Intraosseous Vs. Intravenous Vancomycin Administration in Spine Surgery",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875206",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06875206",
"title": "Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06915662",
"title": "Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap: A Prospective Trial for Safety and Efficacy",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06962280",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06962280",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020026",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07020026",
"title": "Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease Using [18F]PI-2620: A High-resolution PET Imaging Study Using NeuroEXPLORER (NX PI-2160 in PD)",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J. Fox Foundation for Parkinson's Research",
"sponsor_slug": "michael-j-fox-foundation-for-parkinsons-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05536739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05536739",
"title": "Adaptive Hip Exoskeleton for Stroke Survivors With Gait Impairment",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Georgia Institute of Technology",
"sponsor_slug": "georgia-institute-of-technology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999278",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06999278",
"title": "LIGHT - Levothyroxine for Isolated Gestational HypoThyroidism in Women With Recurrent Pregnancy Loss: a Multicenter Randomized, Double-blind, Placebo-controlled Trial - a Study Protocol",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Women's Hospital School Of Medicine Zhejiang University",
"sponsor_slug": "womens-hospital-school-of-medicine-zhejiang-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735534",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06735534",
"title": "The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06865677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06865677",
"title": "Phase II Pilot Study of Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06864403",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06864403",
"title": "Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06999304",
"title": "Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "HealthPartners Institute",
"sponsor_slug": "healthpartners-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740890",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06740890",
"title": "A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06767956",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06767956",
"title": "Phase I/II Study of Combination Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Natalie Galanina",
"sponsor_slug": "natalie-galanina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07033026",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07033026",
"title": "A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NGM Biopharmaceuticals, Inc",
"sponsor_slug": "ngm-biopharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03301805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03301805",
"title": "A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rgene Corporation",
"sponsor_slug": "rgene-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025720",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07025720",
"title": "Personalized Accelerated Intermittent Theta Burst Stimulation for Post-Acute Suicidal Ideation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095660",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07095660",
"title": "RECANA OUS - Recana Thrombectomy Catheter for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intervene, Inc.",
"sponsor_slug": "intervene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05974202",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05974202",
"title": "Augmenting Cognitive-behavioral Therapy With rTMS of the Medial Prefrontal and Anterior Cingulate Cortices for the Treatment of Cocaine Use Disorder",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06392841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06392841",
"title": "Hispanic/Latino and Non-Hispanic BlAck Patients Treated With niRaparib and Abiraterone Acetate Plus Prednisone for Metastatic hOrmone Sensitive Prostate Cancer With Deleterious Homologous recombinatioN Repair Alterations: a Phase II, Open Label studY",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Qian Qin",
"sponsor_slug": "qian-qin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999603",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06999603",
"title": "A Phase 2, Two-part Study to Assess the Safety, Antiviral Biomarker Responses, and Efficacy of Inhaled SNG001 for the Treatment of Patients With a Confirmed Respiratory Virus Infection Undergoing Invasive Mechanical Ventilation",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Synairgen Research Ltd.",
"sponsor_slug": "synairgen-research-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079761",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07079761",
"title": "Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804811",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06804811",
"title": "A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo",
"has_exemption": false,
"start_date": "2025-08-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07051031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07051031",
"title": "Reactogenicity, Patient Reported Outcomes and Vaccine Preference in Adults Immunized With Recombinant Protein or mRNA COVID-19 Vaccines",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marcel Curlin",
"sponsor_slug": "marcel-curlin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419985",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06419985",
"title": "A Phase 2 Single-arm, Open Label Clinical Trial to Evaluate the Efficacy of Ketamine HCl Prolonged Release Tablets in Participants With Complex Regional Pain Syndrome",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06968143",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06968143",
"title": "Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07078604",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07078604",
"title": "A Phase II Trial of the Immunogenicity of a DNA Plasmid-Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes From Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Patients With Metastatic Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02802423",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02802423",
"title": "A Multi-Center, Randomized, Double Blind, Placebo-Controlled, Phase IIA Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid With Adjuvant Chemotherapy in Patients With Triple Negative Breast Cancer (TNBC) After Surgery",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioLite, Inc.",
"sponsor_slug": "biolite-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02438904",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02438904",
"title": "Compassionate Access of the Miltenyi Device for CD34+ Cell Selection",
"has_exemption": false,
"start_date": "2015-05-06",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03793478",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03793478",
"title": "A Phase 1/2, Multicenter, Dose-Escalating Study To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy Of Quizartinib Administered in Combination With Re-Induction Chemotherapy, and as a Single-Agent Continuation Therapy, in Pediatric Relapsed/Refractory AML Subjects Aged 1 Month to <18 Years (and Young Adults Aged up to 21 Years) With FLT3-ITD Mutations",
"has_exemption": false,
"start_date": "2018-08-15",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04256317",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04256317",
"title": "A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2020-05-21",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Oncology, Inc.",
"sponsor_slug": "taiho-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05333458",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05333458",
"title": "A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)",
"has_exemption": false,
"start_date": "2022-08-29",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313165",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05313165",
"title": "Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial",
"has_exemption": false,
"start_date": "2022-12-22",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "LimFlow, Inc.",
"sponsor_slug": "limflow-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06023329",
"title": "Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery",
"has_exemption": false,
"start_date": "2023-01-03",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05524064",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05524064",
"title": "FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05331170",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05331170",
"title": "Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma VIRAL MUCOSAL REPROGRAMMING",
"has_exemption": false,
"start_date": "2023-04-27",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669027",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05669027",
"title": "Effective Self-Management of Chronic Pain With mHealth Neurofeedback",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04808427",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04808427",
"title": "Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation",
"has_exemption": false,
"start_date": "2023-11-20",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06009926",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06009926",
"title": "Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Detoxification of Carcinogens in Firefighters",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05593497",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05593497",
"title": "Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss",
"has_exemption": false,
"start_date": "2024-05-31",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377696",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06377696",
"title": "Neuro-Oncology Anywhere: Deploying Mayo Clinic's Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin on Cognition and Quality of Life in Patients With History of Cranial Radiation",
"has_exemption": false,
"start_date": "2024-05-31",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06308588",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06308588",
"title": "Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548412",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06548412",
"title": "CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424067",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06424067",
"title": "A Phase II Study of Fingolimod in Patients With Non-Small Cell and Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627751",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06627751",
"title": "Phase II Clinical Trial of Mezigdomide/Carfilzomib/Dexamethasone (MeziKD) in Patients With Relapsed or Refractory Multiple Myeloma (MM) With Extramedullary Disease (EMD)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704100",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06704100",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06751992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06751992",
"title": "Neurocognitive Function Changes With Once-Daily Extended-Release Tacrolimus (Envarsus XR) Conversion Compared to Twice-Daily Immediate Release Tacrolimus Maintenance Among Older Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928766",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06928766",
"title": "Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea (OSA) With a Low Arousal Threshold Who Have Difficulty Maintaining or Falling Asleep (ELOSA): A Double-blind, Placebo-controlled, Randomised, Trial.",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Flinders University",
"sponsor_slug": "flinders-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06600698",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06600698",
"title": "Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193317",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06193317",
"title": "Effects of taVNS on Fibromyalgia Pain",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06834607",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06834607",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Akhilesh Jain",
"sponsor_slug": "akhilesh-jain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943534",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06943534",
"title": "Omalizumab Weight-Based Dosing Efficacy Trial",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943664",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06943664",
"title": "Phase II Trial: Photoimmunotherapy and Anti-PD1 in Patients With Refractory Inoperable and Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04381897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04381897",
"title": "Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980038",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06980038",
"title": "A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071961",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07071961",
"title": "Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619236",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06619236",
"title": "A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2027-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029711",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07029711",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ritlecitinib in Pediatric Participants 6 to Less Than 12 Years of Age With Severe Alopecia Areata",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2027-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807268",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06807268",
"title": "A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2027-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03591510",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03591510",
"title": "A Phase II, Open-label, Single Arm Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Twice Daily Midostaurin (PKC412) Combined With Standard Chemotherapy and as a Single Agent Post-consolidation Therapy in Children With Untreated FLT3-mutated AML",
"has_exemption": false,
"start_date": "2019-03-13",
"completion_date": "2027-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02628067",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02628067",
"title": "A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)",
"has_exemption": false,
"start_date": "2015-12-18",
"completion_date": "2027-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07037004",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07037004",
"title": "Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2027-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05897320",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05897320",
"title": "Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine",
"has_exemption": false,
"start_date": "2023-06-08",
"completion_date": "2027-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428396",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06428396",
"title": "A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastic Breast Cancer After Progression on Previous Endocrine Therapy (LITESPARK-029)",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2027-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632600",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06632600",
"title": "A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2027-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05063162",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05063162",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)",
"has_exemption": false,
"start_date": "2022-02-02",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06141473",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06141473",
"title": "Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06138639",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06138639",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)",
"has_exemption": false,
"start_date": "2024-05-06",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Solid Biosciences Inc.",
"sponsor_slug": "solid-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015190",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07015190",
"title": "A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-05-07",
"has_results": false,
"results_due": false,
"sponsor_name": "IDEAYA Biosciences",
"sponsor_slug": "ideaya-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06005610",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06005610",
"title": "Giving Standardized Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2027-05-08",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03229200",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03229200",
"title": "Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.",
"has_exemption": false,
"start_date": "2017-05-22",
"completion_date": "2027-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmacyclics Switzerland GmbH",
"sponsor_slug": "pharmacyclics-switzerland-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06074588",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06074588",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations",
"has_exemption": false,
"start_date": "2023-11-12",
"completion_date": "2027-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06094010",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06094010",
"title": "A Phase IIIb Multicenter, Single-arm, Open-label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05726383",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05726383",
"title": "MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05668741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05668741",
"title": "A Phase 1/2 Dose Escalation Study Evaluating the Safety, and Tolerability and Efficacy of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy",
"has_exemption": false,
"start_date": "2023-02-27",
"completion_date": "2027-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824194",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06824194",
"title": "A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2 Arm Study to Investigate the Safety of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2027-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05327114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05327114",
"title": "Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2022-09-23",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05882877",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05882877",
"title": "A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062420",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06062420",
"title": "A Phase 2, Randomized, Open-label, Platform Study Using a Master Protocol to Evaluate Novel Immunotherapy Combinations as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06230224",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06230224",
"title": "A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, Versus Standard of Care Therapy in Participants With Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06455449",
"title": "A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721156",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06721156",
"title": "A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06847724",
"title": "A Randomized, Double-blind, Parallel-group Study to Compare the Pharmacokinetics, Efficacy, Pharmacodynamics, Safety, and Immunogenicity of CYB704 (Proposed Ocrelizumab Biosimilar) and Ocrevus® (EU-authorized and US-licensed) in Participants With Relapsing Multiple Sclerosis (RMS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sandoz",
"sponsor_slug": "sandoz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05343013",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05343013",
"title": "TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2022-06-06",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05267821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05267821",
"title": "Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05465941",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05465941",
"title": "Phase II Clinical Trial of PLX038 in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445062",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06445062",
"title": "A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06448026",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06448026",
"title": "Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06979362",
"title": "Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2027-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979375",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06979375",
"title": "Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04322370",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04322370",
"title": "Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries",
"has_exemption": false,
"start_date": "2020-08-21",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05878717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05878717",
"title": "A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)",
"has_exemption": false,
"start_date": "2023-09-13",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06736041",
"title": "A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660667",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06660667",
"title": "A Phase 1/2 Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR402663 in Participants With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06671483",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06671483",
"title": "A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06671496",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06671496",
"title": "A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04607954",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04607954",
"title": "Phase II Clinical Trial of Durvalumab (MEDI4736) and Lurbinectedin in Patients With Relapsed Extensive Stage Small Cell Lung Cancer Previously Treated With Chemotherapy and Immunotherapy",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2027-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624554",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05624554",
"title": "A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Without TP53 Aberrations",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2027-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01473628",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01473628",
"title": "Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II",
"has_exemption": false,
"start_date": "2013-05-20",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03958877",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03958877",
"title": "An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension",
"has_exemption": false,
"start_date": "2019-10-18",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568237",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06568237",
"title": "A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Teva Branded Pharmaceutical Products, R&D Inc.",
"sponsor_slug": "teva-branded-pharmaceutical-products-rd-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06465329",
"title": "A Randomized Phase 2 Platform Study to Evaluate Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for the Perioperative Treatment of Patients With Resectable Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311227",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06311227",
"title": "A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05132504",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05132504",
"title": "Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Pembrolizumab Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas",
"has_exemption": false,
"start_date": "2022-08-31",
"completion_date": "2027-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05886634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05886634",
"title": "A Phase II Study of Adenosine Receptor (A2A and A2B) Inhibition (AB928) in Combination With Anti-PD-1 Therapy (AB122) in Patients With Advanced Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2027-05-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049159",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07049159",
"title": "A Two-stage, Phase 2b, Randomized, Double-blind, Placebo-controlled Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-05-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Eveliqure Biotechnologies GmbH",
"sponsor_slug": "eveliqure-biotechnologies-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06157567",
"title": "Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System",
"has_exemption": false,
"start_date": "2022-05-24",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05865028",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05865028",
"title": "Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia",
"has_exemption": false,
"start_date": "2023-05-24",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Elizabeth J Franzmann",
"sponsor_slug": "elizabeth-j-franzmann",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05067140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05067140",
"title": "A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination With Abiraterone in Patients With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05519878",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05519878",
"title": "Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers",
"has_exemption": false,
"start_date": "2022-11-29",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06327113",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06327113",
"title": "A Phase 2 Randomized Study Comparing Subcutaneous Tumescent Antibiotic Administration With Standard of Care for the Treatment of Chronic Wounds",
"has_exemption": false,
"start_date": "2024-05-17",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}